AAAAAA

   
Results: 1-7 |
Results: 7
Purification and characterization of human Syk produced using a Baculovirus expression system
Authors: Baldock, D Graham, B Akhlaq, M Graff, P Jones, CE Menear, K
Citation: D. Baldock et al., Purification and characterization of human Syk produced using a Baculovirus expression system, PROT EX PUR, 18(1), 2000, pp. 86-94
The design and synthesis of thrombin inhibitors: The introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors
Authors: Hayler, J Kane, PD LeGrand, D Lugrin, F Menear, K Price, R Allen, M Cockcroft, XL Ambler, J Butler, K Dunnet, K Mitchelson, A Talbot, M Tweed, M Wills, N
Citation: J. Hayler et al., The design and synthesis of thrombin inhibitors: The introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors, BIOORG MED, 10(14), 2000, pp. 1567-1570
Syk-deficient eosinophils show normal interleukin-5-mediated differentiation, maturation, and survival but no longer respond to Fc gamma R activation
Authors: Lach-Trifilieff, E Menear, K Schweighoffer, E Tybulewicz, VLJ Walker, C
Citation: E. Lach-trifilieff et al., Syk-deficient eosinophils show normal interleukin-5-mediated differentiation, maturation, and survival but no longer respond to Fc gamma R activation, BLOOD, 96(7), 2000, pp. 2506-2510
Optimisation of the P2 pharmacophore in a series of thrombin inhibitors: Ion-dipole interactions with lysine 60G
Authors: Ambler, J Brown, L Cockcroft, XL Grutter, M Hayler, J Janus, D Jones, D Kane, P Menear, K Priestle, J Smith, G Talbot, M Walker, CV Wathey, B
Citation: J. Ambler et al., Optimisation of the P2 pharmacophore in a series of thrombin inhibitors: Ion-dipole interactions with lysine 60G, BIOORG MED, 9(9), 1999, pp. 1317-1322
The discovery of orally available thrombin inhibitors: Optimisation of theP1 pharmacophore
Authors: Ambler, J Bentley, D Brown, L Dunnet, K Farr, D Janus, D Le Grand, D Menear, K Mercer, M Talbot, M Tweed, M Wathey, B
Citation: J. Ambler et al., The discovery of orally available thrombin inhibitors: Optimisation of theP1 pharmacophore, BIOORG MED, 9(8), 1999, pp. 1103-1108
Studies towards the identification of potent, selective and bioavailable thrombin inhibitors
Authors: Ambler, J Baker, E Bentley, D Brown, L Butler, K Butler, P Farr, D Dunnet, K Le Grand, D Hayler, J Janus, D Jones, D Menear, K Mercer, M Smith, G Talbot, M Tweed, M
Citation: J. Ambler et al., Studies towards the identification of potent, selective and bioavailable thrombin inhibitors, BIOORG MED, 9(5), 1999, pp. 737-742
The discovery of orally available thrombin inhibitors: Studies towards theoptimisation of CGH1668
Authors: Ambler, J Baker, E Brown, L Butler, P Farr, D Dunnet, K Le Grand, D Janus, D Jones, D Menear, K Mercer, M Smith, G Talbot, M Tweed, M
Citation: J. Ambler et al., The discovery of orally available thrombin inhibitors: Studies towards theoptimisation of CGH1668, BIOORG MED, 8(24), 1998, pp. 3583-3588
Risultati: 1-7 |